Form 4: United Therapeutics Director Katherine J. Klein Reports Share Tracking Award Exercise and Stock Disposal

Katherine J. Klein, a director at United Therapeutics Corp, reported the exercise of share tracking awards and subsequent disposal of common stock on March 8, 2024.

Summary

• On March 8, 2024, Katherine J. Klein, a director of United Therapeutics Corporation, executed transactions involving share tracking awards and common stock.
• Klein exercised share tracking awards, resulting in the acquisition of 9,791 shares at a price of $123.75.
• Following the exercise, Klein disposed of 9,791 shares of common stock at a price of $243.05.
• After these transactions, Klein directly owns 3,640 shares of common stock and 19,584 share tracking awards.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions, with no inherent positive or negative sentiment. It simply reports facts.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.

Stakeholder Impact

• The transactions may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates